The U.S. Department of Health and Human Services formerly said it would pay Pfizer and biotech company BioNTech $ 1.95 billion to produce and deliver 100 million dosages of their Covid-19 vaccine with the choice to acquire 500 million extra doses. HHS later on announced it would offer Johnson & & Johnson more than $1 billion for 100 million dosages with the choice for an extra 200 million..
The U.S. governments offer with Moderna follows comparable agreements its made with pharmaceutical giants Pfizer, Johnson and Johnson and other drug makers for their prospective Covid-19 vaccines.
Modernas coronavirus vaccine remains in late-stage human trials, which will evaluate its efficacy and security in 30,000 individuals. The Massachusetts-based company previously said it might anticipate results as early as October..
” We are purchasing the development and manufacture of the leading 6 vaccine candidates to guarantee quick shipment. The military is all set to go, theyre ready to provide a vaccine to Americans as quickly as one is totally authorized by the FDA and were extremely close to that approval,” Trump stated throughout an interview at the White House..
The deals belong to the Trump administrations efforts to accelerate the development, manufacturing and distribution of vaccines and treatments to fight the coronavirus under the program called Operation Warp Speed..
Moderna separately stated the offer for its vaccine, mRNA-1273, deserves $1.53 billion and will offer the federal government the alternative to acquire as much as 400 million additional dosages. The U.S. has currently invested $955 million in Modernas vaccine advancement, bringing its overall investment approximately $2.48 billion, the business said in a press release Tuesday..
Previously on Tuesday, HHS Secretary Alex Azar told ABCs “Good Morning America” that the operation is on track to produce “10s of millions of doses by December of FDA-gold-standard vaccine and numerous countless dosages as we go into the new year.”.
President Donald Trump on Tuesday revealed the U.S. federal government will acquire 100 million dosages of Modernas experimental coronavirus vaccine, which is currently in late-stage human trials..
Bancel said on Modernas second-quarter earnings call on Aug. 5 that the business would price its vaccine ” well-below worth” during the pandemic period and will price it at market worth once the infection is under control..
— CNBCs Berkeley Lovelace Jr. added to this report..
HHS also struck an offer with Sanofi and GlaxoSmithKline for up to $2.1 billion to deliver and establish 100 million doses of their possible coronavirus vaccine with the choice to obtain an additional 500 million doses..
” We value the self-confidence of the U.S. federal government in our mRNA vaccine platform and the continued support,” Moderna CEO Stephane Bancel stated in a news release..